Nathan Berkowitz
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- RNA Research and Splicing 3
- RNA and protein synthesis mechanisms 3
- RNA modifications and cancer 3
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
- Co-authors
- Brian D. Gregory (4 shared papers)Matthew R. Willmann (2 shared papers)Ian M. Silverman (2 shared papers)Sager J. Gosai (1 shared paper)H. G. Archie Bouwer (1 shared paper)M. J. Montfort (1 shared paper)Darren E. Higgins (1 shared paper)Christine Alberti‐Segui (1 shared paper)
- Journals
- Methods (1 paper)Nature Genetics (1 paper)BMJ Open (1 paper)Advances in experimental medicine and biology (1 paper)Non-Coding RNA (1 paper)
- Partner nations
- United StatesTürkiye
In The Last Decade
Nathan Berkowitz
7 papers receiving 140 citations
Peers
Comparison fields: 5 of 47
- Infectious Diseases 33
- Endocrinology 7
- Molecular Biology 90
- Cancer Research 16
- Plant Science 31
Countries citing papers authored by Nathan Berkowitz
This map shows the geographic impact of Nathan Berkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Berkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Berkowitz more than expected).
Fields of papers citing papers by Nathan Berkowitz
This network shows the impact of papers produced by Nathan Berkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Berkowitz. The network helps show where Nathan Berkowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Berkowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 44 | |
| 2 | 2022 | 42 | |
| 3 | 2016 | 18 | |
| 4 | 2006 | 13 | |
| 5 | 2016 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2022 | 5 |
About Nathan Berkowitz
Nathan Berkowitz is a scholar working on Molecular Biology, Infectious Diseases, Oncology, Biotechnology and Plant Science, having authored 7 papers that have together received 145 indexed citations. Recurring topics across this work include RNA Research and Splicing (3 papers), RNA and protein synthesis mechanisms (3 papers), RNA modifications and cancer (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers), Plant Molecular Biology Research (1 paper), PARP inhibition in cancer therapy (1 paper) and Plant nutrient uptake and metabolism (1 paper). The work is most often cited by research in Infectious Diseases (33 citations), Endocrinology (7 citations), Molecular Biology (90 citations), Cancer Research (16 citations) and Plant Science (31 citations). Nathan Berkowitz has collaborated with scholars based in United States and Türkiye. Frequent co-authors include Brian D. Gregory, Matthew R. Willmann, Ian M. Silverman, Sager J. Gosai, H. G. Archie Bouwer, M. J. Montfort, Darren E. Higgins, Christine Alberti‐Segui, Miao Zhang and Hilal Kazan. Their work appears in journals such as Methods, Nature Genetics, BMJ Open, Advances in experimental medicine and biology and Non-Coding RNA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.